(CS) AXA - Overview
Sector: Financial Services | Industry: Insurance - Diversified | Exchange: PA (France) | Market Cap: 79.904m EUR | Total Return: 2% in 12m
Industry Rotation: +5.0
Avg Turnover: 137M
Warnings
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
AXA SA is a Paris-based global provider of insurance, asset management, and banking services. Operating across diverse geographical segments including Europe, Asia, and Africa, the company maintains a comprehensive portfolio encompassing life, savings, property, and casualty insurance. Its business model relies heavily on risk diversification through its AXA XL division, which provides specialized reinsurance and commercial coverage for complex liabilities such as environmental, marine, and aviation risks.
The company integrates technology into its service delivery through digital ecosystems, including the AXA Multilink platform and generative AI assistants for customer interaction. As a multi-line insurer, AXA benefits from a balanced revenue stream derived from both retail premiums and institutional asset management fees, a structure common among large-scale European financial conglomerates. For a deeper look into the companys financial health, investors can review detailed valuation metrics on ValueRay.
Founded in 1852, AXA has evolved into a global systemic insurer with a significant presence in both mature and emerging markets. Its operations extend beyond traditional indemnity to include healthcare solutions, teleconsultation services, and integrated risk management consulting for corporate clients.
- AXA XL commercial lines pricing power drives underwriting margin expansion
- High interest rates bolster investment income and life insurance profitability
- European regulatory changes and Solvency II ratios impact capital return capacity
- Expansion of health and protection services increases fee-based revenue streams
- Natural catastrophe frequency and severity volatility affects property and casualty earnings
| Net Income: 15.65b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 3.52 > 1.0 |
| NWC/Revenue: 26.18% < 20% (prev 60.26%; Δ -34.08% < -1%) |
| CFO/TA 0.05 > 3% & CFO 33.50b > Net Income 15.65b |
| Net Debt (40.02b) to EBITDA (15.78b): 2.54 < 3 |
| Current Ratio: error (cannot be calculated; needs correct Total Current Assets and Liabilities) |
| Outstanding Shares: last quarter (2.03b) vs 12m ago -8.98% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 27.51% > 50% (prev 29.03%; Δ -1.52% > 0%) |
| Interest Coverage Ratio: 11.68 > 6 (EBITDA TTM 15.78b / Interest Expense TTM 906.0m) |
| A: 0.07 (Total Current Assets 46.10b - Total Current Liabilities 0.0) / Total Assets 635.50b |
| B: 0.07 (Retained Earnings 41.41b / Total Assets 635.50b) |
| C: 0.02 (EBIT TTM 10.59b / Avg Total Assets 639.97b) |
| D: 0.10 (Book Value of Equity 56.73b / Total Liabilities 586.00b) |
| Altman-Z'' = 0.90 = BB |
| DSRI: 2.57 (Receivables 23.90b/9.90b, Revenue 176.09b/187.11b) |
| GMI: 1.01 (GM 101.1% / 102.4%) |
| AQI: 1.23 (AQ_t 0.92 / AQ_t-1 0.75) |
| SGI: 0.94 (Revenue 176.09b / 187.11b) |
| TATA: -0.03 (NI 15.65b - CFO 33.50b) / TA 635.50b) |
| Beneish M = -1.66 (Cap -4..+1) = CCC |
Over the past week, the price has changed by +1.60%, over one month by +0.22%, over three months by +6.76% and over the past year by +1.97%.
| Analysts Target Price | - | - |
P/E Trailing = 11.4854
P/E Forward = 9.9701
P/S = 0.8438
P/B = 1.7698
P/EG = 1.2122
Revenue TTM = 176.09b EUR
EBIT TTM = 10.59b EUR
EBITDA TTM = 15.78b EUR
Long Term Debt = 60.49b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.78b EUR (from shortTermDebt, last fiscal year)
Debt = 62.27b EUR (corrected: LT Debt 60.49b + ST Debt 1.78b)
Net Debt = 40.02b EUR (recalculated: Debt 62.27b - CCE 22.25b)
Enterprise Value = 119.93b EUR (79.90b + Debt 62.27b - CCE 22.25b)
Interest Coverage Ratio = 11.68 (Ebit TTM 10.59b / Interest Expense TTM 906.0m)
EV/FCF = 3.68x (Enterprise Value 119.93b / FCF TTM 32.60b)
FCF Yield = 27.18% (FCF TTM 32.60b / Enterprise Value 119.93b)
FCF Margin = 18.51% (FCF TTM 32.60b / Revenue TTM 176.09b)
Net Margin = 8.89% (Net Income TTM 15.65b / Revenue TTM 176.09b)
Gross Margin = unknown ((Revenue TTM 176.09b - Cost of Revenue TTM -1.90b) / Revenue TTM)
Tobins Q-Ratio = 0.19 (Enterprise Value 119.93b / Total Assets 635.50b)
Interest Expense / Debt = 0.48% (Interest Expense 299.0m / Debt 62.27b)
Taxrate = 21.88% (1.05b / 4.79b)
NOPAT = 8.27b (EBIT 10.59b * (1 - 21.88%))
Current Ratio = unknown (Total Current Assets 46.10b / Total Current Liabilities 0.0)
Debt / Equity = 1.32 (Debt 62.27b / totalStockholderEquity, last quarter 47.20b)
Debt / EBITDA = 2.54 (Net Debt 40.02b / EBITDA 15.78b)
Debt / FCF = 1.23 (Net Debt 40.02b / FCF TTM 32.60b)
Total Stockholder Equity = 46.03b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.44% (Net Income 15.65b / Total Assets 635.50b)
RoE = 33.99% (Net Income TTM 15.65b / Total Stockholder Equity 46.03b)
RoCE = 9.94% (EBIT 10.59b / Capital Employed (Equity 46.03b + L.T.Debt 60.49b))
RoIC = 7.19% (NOPAT 8.27b / Invested Capital 115.00b)
WACC = 3.58% (E(79.90b)/V(142.18b) * Re(6.08%) + D(62.27b)/V(142.18b) * Rd(0.48%) * (1-Tc(0.22)))
Discount Rate = 6.08% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: -82.22 | Cagr: -6.97%
[DCF] Terminal Value 88.44% ; FCFF base≈23.72b ; Y1≈29.26b ; Y5≈49.92b
[DCF] Fair Price = 692.2 (EV 1448.14b - Net Debt 40.02b = Equity 1408.12b / Shares 2.03b; r=6.0% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 90.81 | EPS CAGR: 18.42% | SUE: 0.0 | # QB: 0
Revenue Correlation: -20.76 | Revenue CAGR: -4.24% | SUE: 0.21 | # QB: 0
EPS current Year (2026-12-31): EPS=4.12 | Chg30d=-0.24% | Revisions=-27% | GrowthEPS=+6.7% | GrowthRev=+21.9%
EPS next Year (2027-12-31): EPS=4.45 | Chg30d=+0.10% | Revisions=+0% | GrowthEPS=+8.1% | GrowthRev=+7.1%
[Analyst] Revisions Ratio: -27%